Key Takeaways
- FY25 a recovery year, FY26 guided higher: After a dip in FY24, volumes, revenue and operational EBITDA all rose, led by Packaging Films and a turnaround in Nigeria. Management expects 10% revenue growth and 12.5–13% EBITDA margins in FY26.
- Aseptic Packaging is the star, now capacity-constrained: The business ran at >110% utilization (787 crore packs on 700 crore capacity), and a debottlenecking due in Q1 is the near-term unlock. Egypt adds a second geography.
- The film cycle is turning, but BOPP adds risk: Industry margins troughed in 2024 after a capacity deluge; volumes and prices are recovering. However, 20,000 tons of BOPP capacity lands in India over the next 3–4 months, a near-term margin wildcard.
- Debt stays high, with no equity fix: The only deleveraging path is amortization (~₹1,175 cr/year); management ruled out equity raises. Capex of ~₹1,200 cr in FY26 means net debt will be flat, and the debt-to-equity anchor is 3.6x.
- What to watch next quarter: Whether the Aseptic debottlenecking commissions on time, how BOPP spreads react to the new capacity, and any signal on FY27 visibility, which management says it lacks for now.
Packaging Films: Cycle, Capacity & Margins
- The cycle narrative: The commodity film business runs on 7–10 year cycles. 2016 saw demand-supply mayhem; COVID brought stabilization and then supernormal profits in 2021–22. That drew in heavy capacity additions in India across both BOPET and BOPP, including new small players, which crushed margins in 2024. Volumes ramped up in 2025 and prices are now improving.
- Export valve working: Indian manufacturers exported heavily to Europe to absorb domestic oversupply, which lifted domestic prices. Overseas realizations still exceed Indian prices, so the valve remains open.
- BOPP near-term risk: At least 20,000 tons of BOPP capacity is being added in India over the next 3–4 months, into a market that consumes 84,000–90,000 tons a month. Management hopes this cycle avoids the "madness" of the 2023 PET wave because the players are larger, established names, but concedes only time will tell how competition stacks up.
- BOPET outlook: Poland utilization improved from 60% in Q3 to 70% in Q4 but remains under pressure from Indian imports. Management expects European operations to improve over the next year as India's demand-supply gap narrows.
- Margin guidance: FY26 Packaging Films industry margins guided to 10–11%, with BOPP facing some competition and BOPET improving a bit. Longer term, management expects a return to the historical 14–15% EBITDA margin range, excluding the COVID super-cycle years.
- No new Uflex capacity: Uflex has no BOPET or BOPP capacity additions planned, so it rides the cycle without adding its own supply.
Rajesh Bhatia: "But again, only time will tell as to how the competition stacks up in this category, now that in the next 3 months also, we're going to see at least 20,000 tons of capacity being added in a market -- in the Indian market, which consumes about 84,000 to 90,000 tons a month."
Aseptic Packaging: The Capacity-Constrained Star
- Performance: 787 crore packs produced on 700 crore packs of nameplate capacity, crossing 110% utilization. The business has been the company's standout performer for several years and management expects that to continue.
- Debottlenecking: A capacity expansion via debottlenecking is expected to commission in Q1, though management declined to give a precise date. This is the immediate growth unlock.
- Egypt plant: A new facility with 1,200 crore packs of capacity is commissioning in FY26. Egypt itself consumes ~500 crore packs annually and imports 100% of them, plus the plant offers duty-advantaged access to Europe and Africa. Management is "100% sure" it will be a success story, though the ramp-up may take time, as it did in India.
- FY26 volume guidance: 1,000–1,050 crore packs, reflecting the debottlenecking contribution. No further India capacity is needed for a few more years; Egypt can serve export markets, freeing India for domestic demand.
Rajesh Bhatia: "I will always have to cover the Aseptic Packaging because that's been a shining star for a few years now and will remain so in the future."
Debt, Capex & the Balance Sheet
- Debt repayment plan: ~₹1,175 crores of long-term debt scheduled for repayment in FY26. If no further expansion is undertaken, a similar amount can be repaid each year for the next couple of years.
- Capex offsets the repayment: ~₹1,200 crores of capex is planned for FY26 across ongoing projects (WPP bags in Mexico, recycling in Noida, Aseptic Egypt). Capex-related debt drawdowns will roughly offset repayments, so net debt is expected to stay flat in FY26.
- Working capital: Additional working capital for existing and new businesses will need to be funded from bank lines, adding a separate layer of borrowing.
- No equity route: Management was explicit that it is not considering any equity raise, ESOPs, or other methods to reduce debt. The only deleveraging mechanism is amortization. When the investment cycle eventually stops, debt will decline.
- Debt anchor: Management pegged 3.6x debt-to-equity as the reference point and overall guidance level for future debt. Debt-to-EBITDA could reach ~3.9x in FY26/FY27, which may constrain further expansion appetite.
- Overseas listing shelved: Plans to list an overseas subsidiary were initiated but the market window closed; near-term equity raising is off the table. Management may revisit equity at the Dubai holding level if an opportunity arises after two years.
Rajesh Bhatia: "Other than the normal amortizations what we have with our lenders, there is no other way that we are looking at from raising any equity or by doing anything else, we are not looking at reducing the debt at present."
New Projects & Recycling
- Mexico WPP bags: A plant serving the pet food industry is commissioning in FY26, with a target EBITDA margin of 22–24% and full-capacity turnover of \$50 million.
- Recycling facility, Noida: A ₹317 crore investment in a mechanical recycling plant is commissioning later this year. It includes a PCR line that converts old PET bottles into film, with demand expected to rise as brand owners must meet recycling commitments from 1 April under EPR rules. Management sees mechanical recycling as the proven, cleaner path and wants a couple of years before drawing definitive conclusions.
- PET chips facility, Panipat: Achieved 72% capacity utilization in its first year, with headroom to increase.
- Future expansion posture: Management and the board will evaluate opportunities as they arise and remain keen to expand, but will stay "very aware" of debt levels. The 3.9x debt-to-EBITDA ceiling may act as a natural brake.
Rajesh Bhatia: "Mechanical is more cleaner and you know that you can use the old pack bottles to make the raw material for your polyester packaging films. You can use that for your rigid packaging bottles as well. So, it looks like that mechanical is the answer as of now, but let's wait for the next couple of years before we have more definitive answers on this."
Business Mix & Profitability Dynamics
- Natural hedge within the portfolio: When Packaging Film prices fall, the Packaging Business benefits because it holds orders in hand and buys raw materials at lower cost. The reverse also holds. This dynamic was visible in Q4, when film market prices softened versus Q3 and year-end provisions weighed on Packaging Films profitability, while the downstream Packaging Business gained.
- Non-film profitability premium: Holographic, Engineering and other non-film businesses carry "definitely better" profitability than Packaging Films.
- Chemical business: Profitability improved in FY25 over FY24 and did not dip.
- Geographic margin dispersion: Nigeria, India, the US and Europe each carry different margin profiles, so management discusses only blended averages. Nigeria's turnaround was a material contributor to the FY25 improvement.
- Crude oil sensitivity: Packaging Films adjusts pricing on a real-time or one-month lag basis, so large crude-driven raw material swings are not expected to cause big deviations at the overall company level.
Rajesh Bhatia: "if there is a loss in the Packaging Film business, there will be a better margin in the Packaging Business because the Packaging Business will always gain -- perform better when the Packaging Film prices go down and vice versa"
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | ~10% top-line growth to ~₹16,700 crores | FY26 |
| EBITDA margin | 12.5–13% margin, ~₹2,100 crores EBITDA | FY26 |
| Aseptic volume | 1,000–1,050 crore packs | FY26 |
| Aseptic debottlenecking | Commissioning of capacity expansion | Q1 FY26 |
| Long-term debt repayment | ~₹1,175 crores repaid | FY26 |
| Capex spend | ~₹1,200 crores on ongoing projects | FY26 |
| Mexico WPP plant | Commissioning; 22–24% EBITDA margin target | FY26 |
| Aseptic Egypt plant | Commissioning | FY26 |
| Recycling facility, Noida | Commissioning; benefits begin rolling in | Later this year |
| Packaging Films margins (long-term) | Return to 14–15% EBITDA margin range | Next couple of years |
| Debt-to-equity anchor | 3.6x as reference point | Ongoing |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Consolidated revenue | Over ₹15,000 cr, +12.4% YoY for FY25 |
| Operational EBITDA growth | ~18% YoY for FY25 |
| PAT | ~₹142 cr for FY25, vs loss of ~₹690 cr in FY24 |
| Exceptional loss | ~₹177 cr in Egypt and Nigeria for FY25, vs ₹871 cr in FY24 |
| Packaging Films volume growth | ~10.4% YoY for FY25 |
| Packaging Films sales growth | 10.3% YoY for FY25 |
| Packaging Films production and sales volume | Over 500,000 tons for FY25, first time achieved |
| Packaging Films share of total business | 62.3% |
| Aseptic Packaging production | 787 cr packs on 700 cr packs capacity, >110% utilization for FY25 |
| Aseptic Packaging volume guidance | 1,000 cr to 1,050 cr packs for FY26 |
| PET chips capacity utilization | 72% at Panipat plant, first year of operation |
| Gross debt | ~₹8,100 cr as of 31 March 2025 |
| Net debt | ~₹6,800 cr as of 31 March 2025 |
| Cash balance | ₹1,273 cr as of 31 March 2025 |
| Long-term debt repayment planned | ~₹1,175 cr for FY26 |
| Capex spent | ₹668 cr in Q4 FY25, ₹1,726 cr for FY25 |
| Capex planned | ~₹1,200 cr for FY26 |
| Debt-to-EBITDA | 3.6x at end of FY25, max ~3.9x expected in FY26/FY27 |
| FY26 revenue growth guidance | 10% over ~₹15,000 cr, implying ~₹16,700 cr |
| FY26 EBITDA guidance | ~₹2,100 cr, based on 12.5% to 13% margin |
| BOPP and BOPET blended EBITDA margin | ~10% currently, industry range 10% to 11% |
| BOPP capacity addition in India | At least 20,000 tons in next 3 months, market consumes 84,000–90,000 tons/month |
| Poland plant capacity utilization | 70% in Q4, up from 60% in Q3 |
| Mexico pet food packaging expected EBITDA margin | 22% to 24% |
| Mexico plant turnover at full capacity | \$50 million, approx ₹450 cr |
| Noida recycling investment | ₹317 cr, commissioning expected by end of FY26 |